Skip to Content
Search Menu

ASCO | American Society of Clinical Oncology

ASCO 2025

Bjørn H Grønberg

ASCO 2026: No Survival Benefit With Thoracic Radiotherapy in SCLC

/ Bjørn Henning Grønberg
ASCO26Lung cancer Play the Video

ASCO 2024

Thorgerdur Palsdottir

The Capio Model for Prostate Cancer Diagnostics

/ Thorgerdur Palsdottir
ASCO24Prostate cancer Play the Video

Don't miss out on the newest findings and news in your area of expertise

Sign up as a user, and receive the newest articles, MEDtalks and magazines directly in your inbox.

Sign up
Joaquim Bellmunt

First-Line Maintenance Therapy with Avelumab Show Significantly Prolonged OS and PFS in Patients with Advanced Urothelial Cancer with Low Tumor Burden

/ Joaquim Bellmunt
ASCO24Bladder cancer Play the Video
Cathy Burton

Paradigm Changes in Hodgkin’s Lymphoma Treatments

/ Cathy Burton
ASCO24Hodgkin's lymphomaLymphoma Play the Video
Oluf Dimitri Røe

ASCO24: Very Exciting Steps for Early Diagnosis and Lung Cancer

/ Oluf Dimitri Røe
ASCO24Lung cancer Play the Video

Trastuzumab Deruxtecan Significantly Improves Progression-Free Survival in Breast Cancer Patients Previously Treated with Endocrine Therapy

/ Sofie Pohl
ASCO24
Oluf Dimitri Røe

Oluf Dimitri Røe: ASCO Is the Cradle of Oncology

/ Oluf Dimitri Røe
ASCO24 Play the Video

ASCO 2023

Oluf Dimitri Røe

Can We Predict Bladder Cancer Using the HUNT Model?

/ Oluf Dimitri Røe
ASCO23Bladder cancer Play the Video
Stine Bakkensen Bruun

Circulating Methylated-HOXA9 Tumor DNA as a Biomarker in Recurrent Breast Cancer

/ Stine Bakkensen Bruun
ASCO23Breast cancer Play the Video
Lars Henrik Jensen

Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Does Not Change OS

/ Lars Henrik Jensen
ASCO23Bowel cancer Play the Video

Significant PFS Benefit for the Nivolumab + Relatlimab Combination for Patients with Unresectable or Metastatic Melanoma

/ BestPractice Nordic
ASCO23Melanoma

Adjuvant Osimertinib – New Standard of Care for Patients with Resected EGFR-mutated NSCLC

/ BestPractice Nordic
ASCO23Lung cancer

Adjuvant Pembrolizumab Continue to Demonstrate Significant Improvements for Patients with Stage IIB/IIC Melanoma

/ BestPractice Nordic
ASCO23Melanoma

Prolonged Progression-Free Survival in Patients with Advanced Ovarian Cancer

/ BestPractice Nordic
ASCO23Gynecological cancer

Pan Tumor Study – Effectively Treatment for HER2-Expressing Cancers Regardless of Tumor Location

/ BestPractice Nordic
ASCO23CancerHER2
Sagar Lonial

Exciting News for CAR T Cell Therapy to Heavily Treated Patients with Multiple Myeloma

/ Sagar Lonial
ASCO23CAR-TEHA23Myelooma Play the Video
Load more

Don't miss out on the latest news and findings within the field of hematology

Register and receive the newest articles, MEDtalk videos and magazines directly in your email.

Sign up

ASCO 2022

Martin Hutchings

Promising Findings for R/R Large B-Cell Lymphoma – Glofitama and Epcoritamab Show Curative Potential

/ Martin Hutchings
ASCO22B-Cell LymphomaEHA23Lymphoma Play the Video
Jeanne Tie

The randomized DYNAMIC Trial: ctDNA-guided approach towards adjuvant chemotherapy

/ Jeanne Tie
ASCO22Colorectal cancer Play the Video
David Cella, Dr

HRQoL as Prognostic Value for Overall Survival in Patients with RCC Receiving ICIs

/ David Cella
ASCO22Kidney cancer Play the Video

Novel Agent Increases PFS for Patients with endocrine-resistant HR+/HER2- metastatic breast cancer

/ BestPractice Nordic
ASCO22Cancer

Ibrutinib added to Standard-of-Care Therapy improves PFS by 50% for Older Patients with Newly Diagnosed Mantle Cell Lymphoma

/ BestPractice Nordic
ASCO22Lymphoma

Health-related quality of life is associated with clinical outcomes in patients with advanced renal cell carcinoma

/ BestPractice Nordic
ASCO22Kidney cancer
Load more

More from ASCO

Live Fagereng

ASCO 2026: PRIME-ROSE and Implementation of Precision Cancer Medicine in Europe

/ Live Fagereng
ASCO26Cancer Play the Video
Martin Højgaard

ASCO 2026: Selective PARP1 Inhibitor Shows Encouraging Early Results

/ Martin Højgaard
ASCO26Breast cancerOvariecancer Play the Video
Luis Paz-Ares

ASCO 2025: Lurbinectedin–Atezolizumab Improves Survival in SCLC

/ Luis Paz-Ares
ASCO25Lung cancer Play the Video
Andreas Koulouris

Lung Cancer: Even Small Tumor Volumes Worsen Prognosis and Increase Risk of Complications After SRS

/ Andreas Koulouris
ASCO25 Play the Video
Jean Bourhis

ASCO 2025: Nivolumab + chemoradiotherapy improves disease-free survival in Head and Neck Cancer

/ Jean Bourhis
ASCO25Colorectal cancer Play the Video
Inna Markovna Chen

ASCO 2025: Chemo-Immunotherapy Combined with Stereotactic Radiation Shows Promise in Pancreatic Cancer

/ Inna Markovna Chen
ASCO25 Play the Video
Sara Tolaney

ASCO 2025: Redefining First-Line Therapy in HER2+ Breast Cancer with T-DXd and Pertuzumab

/ Sara Tolaney
ASCO25Breast cancerNBCN Play the Video

Toward a New Standard of Care: Sacituzumab and Pembrolizumab in PD-L1+ mTNBC

/ Jan Andreasen
ASCO25NBCN
Load more

Back to top